Endocannabinoids modulate non-adrenergic, non-cholinergic inhibitory neurotransmission in strips from the mouse gastric fundus

Acta Physiologica

Volumn 206, Issue 1, 2012, Pages 80-87

  Garella, R ^a   Baccari, M C ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Anandamide; Endocannabinoids; Gastric; Nitric oxide; Peptidergic neurotransmission

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CARBACHOL; CHYMOTRYPSIN A; ENDOCANNABINOID; GASTROINTESTINAL POLYPEPTIDE; N(G) NITROARGININE; TETRODOTOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRIC FIELD; FEMALE; ISOMETRICS; MOUSE; NEUROTRANSMISSION; NITRERGIC NERVE; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; STOMACH FUNDUS;

ANIMALS; CANNABINOID RECEPTOR AGONISTS; CANNABINOID RECEPTOR ANTAGONISTS; ENDOCANNABINOIDS; FEMALE; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, CANNABINOID; STOMACH; SYNAPTIC TRANSMISSION;

EID: 84864523224     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2012.02444.x     Document Type: Article

References (34)

1. Abalo, R., Cabezos, P.A., Vera, G., Lòpez-Miranda, V., Herradòn, E. & Martin-Fontelles, M.I. 2011. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors. Neurogastroenterol Motil 23, 457-467.
2. Baccari, M.C. & Calamai, F. 2001. Modulation of nitrergic relaxant responses by peptides in the mouse gastric fundus. Regul Pept 98, 27-32.
3. Baccari, M.C., Bani, D. & Calamai, F. 2009. Evidence for a modulatory role of orexin A on the nitrergic neurotransmission in the mouse gastric fundus. Regul Pept 154, 54-59.
4. Begg, M., Dale, N., Llaudet, E., Molleman, A. & Parson, M.E. 2002. Modulation of the release of endogenous adenosine by cannabinoids in the myenteric plexus-longitudinal muscle preparation of the guinea-pig ileum. Br J Pharmacol 137, 1298-1304.
5. Boeckxstaens, G.E., Pelckmans, P.A., De Man, J.G., Bult, H., Herman, A.G. & Van Maerke, Y.M. 1992. Evidence for a differential release of nitric oxide and vasoactive intestinal peptide by non-adrenergic, non-cholinergic nerves in the rat gastric fundus. Arch Int Pharmacodyn Ther 318, 107-115.
6. 1 receptors in the mouse gastroenteric tract. Eur J Pharmacol 459, 97-105.
7. Cota, D. 2007. CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health. Diabetes Metab Rev 23, 507-517.
8. Coutts, A.A. & Pertwee, R.G. 1997. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br J Pharmacol 121, 1557-1566.
9. Coutts, A.A., Irving, A.J., Mackie, K., Pertwee, R.G. & Anavi-Goffer, S. 2002. Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexus. J Comp Neurol 448, 410-422.
10. Croci, T., Manara, L., Aureggi, G., Guagnini, F., Rinaldi-Carmona, M., Maffrand, J.P., Le Fur, G., Mukenge, S. & Ferla, G. 1998. In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br J Pharmacol 125, 1393-1395.
11. De Petrocellis, L., Orlando, P., Moriello, A.S., Aviello, G., Stott, C., Izzo, A.A. & Di Marzo, V. 2012. Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. Acta Physiol 204, 255-266.
12. Desai, K.M., Zembowicz, A., Sessa, W.C. & Vane, J.R. 1991. Nitroxidergic nerves mediate vagally-induced relaxation in the isolated stomach of the guinea-pig. Proc Natl Acad Sci 88, 11490-11494.
13. Duncan, M., Davison, J.S. & Sharkey, K.A. 2005. Review article: endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther 22, 667-683.
14. Duncan, M., Mouihate, A., Mackie, K., Keenan, C.M., Buckley, N.E., Davison, J.S., Patel, K.D., Pittman, Q.J. & Sharkey, K.A. 2008. Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats. Am J Physiol 295, G78-G87.
15. Garella, R. & Baccari, M.C. 2010. Contribution of endogenous nitrergic and peptidergic influences to the altered neurally-induced gastric contractile responses in strips from dystrophic (mdx) mice. Regul Pept 160, 57-63.
16. Hinds, N.M., Ullrich, K. & Smid, S.D. 2006. Cannabinoid 1 (CB1) receptors coupled to cholinergic motoneurons inhibit neurogenic circular muscle contractility in the human colon. Br J Pharmacol 148, 191-199.
17. Howlett, A.C., Barth, F., Bonner, T.I., Cabral, G., Casellas, P., Devane, W.A., Felder, C.C., Herkenman, M., Mackie, K., Martin, B.R., Mechoulam, R. & Pertwee, R.G. 2002. Classification of cannabinoid receptors. Pharmacol Rev 54, 161-202.
18. Izzo, A.A. & Sharkey, K.A. 2010. Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther 126, 21-38.
19. Jin, J.G., Katsoulis, S., Schmidt, W.E. & Grider, J.R. 1994. Inhibitory transmission in tenia coli mediated by distinct vasoactive intestinal peptide and apamine-sensitive pituitary adenylate cyclase activating peptide receptors. J Pharmacol Exp Ther 270, 433-439.
20. Kulkarni-Narla, A. & Brown, D.R. 2000. Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system. Cell Tissue Res 302, 73-80.
21. Kurjak, M., Hamel, A.M., Allescher, H.D., Schusdziarra, V. & Storr, M. 2008. Differential stimulatory effects of cannabinoids on VIP release and NO synthase activity in synaptosomal fractions from rat ileum. Neuropeptides 42, 623-632.
22. Lefebvre, R.A. 1993. Non-adrenergic, non-cholinergic neurotransmission in the proximal stomach. Gen Pharmacol 24, 257-266.
23. Mulè, F., Amato, A., Baldassano, S. & Serio, R. 2007a. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon. Pharmacol Res 56, 132-139.
24. Mulè, F., Amato, A., Baldassano, S. & Serio, R. 2007b. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations. Pharmacol Res 56, 185-192.
25. Pertwee, R.G. 2001. Cannabinoids and the gastrointestinal tract. Gut 48, 859-867.
26. Rand, M.J. 1992. Nitrergic transmission: nitric oxide as mediator of non-adrenergic, non-cholinergic neuro-effector transmission. Clin Exp Pharmacol Physiol 19, 147-169.
27. Savinainen, J.R., Saario, S.M. & Laitinen, J.T. 2012. The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. Acta Physiol 204, 267-276.
28. Stark, M.E. & Szurszewski, J.H. 1992. Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 103, 1928-1949.
29. Storr, M., Gaffal, E., Saur, D., Schusdziarra, V. & Allescher, H.D. 2002. Effects of cannabinoids on neural transmission in rat gastric fundus. Can J Physiol Pharmacol 80, 67-76.
30. Storr, M., Sibaev, A., Morsicano, G., Lutz, B., Schusdziarra, V., Timmermans, J.P. & Allescher, H.D. 2004. Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon. Am J Physiol 286, G110-G117.
31. Sundler, F., Ekblad, E., Absood, A., Hakanson, R., Koves, K. & Arimura, A. 1992. Pituitary adenylate cyclase activating polypeptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut. Neuroscience 46, 439-454.
32. Takahashi, T. & Owyang, C. 1995. Vagal control of nitric oxide and vasoactive intestinal polypeptide release in the regulation of gastric relaxation in rat. J Physiol 484, 481-492.
33. Torodov, S., Pozzoli, C., Zamfirova, R. & Poli, E. 2003. Prejunctional modulation of non-adrenergic non-cholinergic (NANC) inhibitory responses in the isolated guinea-pig gastric fundus. Neurogastroenterol Mot 15, 299-306.
34. Van Geldre, L.A. & Lefebvre, R.A. 2004. Interaction of NO and VIP in gastrointestinal smooth muscle relaxation. Curr Pharm Des 10, 2483-2497.